### Consensus provenance reconciliation — 9 October 2026

Case-specific Consensus discovery records were located and linked to this final edition. This supplements the review's provenance; it leaves the original assessed claim, grades and source counts intact. Provider summaries and full-text badges do not establish examination of original primary passages by this reviewer. Source access and incorporation retain the limits stated in the original methods and any dated research update.

Recorded evidence artifacts:

- `deliverables/hsef_v53_neurodegeneration_2026-10-03/antimicrobial-amyloid/consensus/consensus-evidence-cards.json`
- `deliverables/hsef_v53_neurodegeneration_2026-10-03/antimicrobial-amyloid/consensus/consensus-evidence-cards.md`
- `deliverables/hsef_v53_neurodegeneration_2026-10-03/antimicrobial-amyloid/discovery/consensus-discovery.json`
- `deliverables/hsef_v53_popularity_ranks_41_45_2026-10-08/antimicrobial-amyloid/consensus/broad-ax.txt`
- `deliverables/hsef_v53_popularity_ranks_41_45_2026-10-08/antimicrobial-amyloid/consensus/reconciliation.md`

Reported usage is preserved in the linked source-specific records; query counts and original-passage comparisons are different measures.

A dated adversarial approval record exists for the separately identified antimicrobial-amyloid.review.md (2026-10-06; see edition-approval-audit.json). Its scope is that recorded edition. This supplement has no separate approval and no coverage is inferred from topic identity. No score or confidence change is made by this reconciliation.